
Overview
Background
Alexander Khromykh has PhD degree in Molecular Virology. He worked as Postdoctoral Fellow at the University of Ottawa in Canada. He then joined Sir Albert Sakzewski Virus Research Centre in Brisbane and became a laboratory Head in 2001. He moved his laboratory to St Luica campus in 2005 to take an appointment with the School of Chemistry and Molecular Biosciences (SCMB). He was the founding Director of the SCMB’s Centre for Infectious Disease Research and is currently the Deputy Director of the Australian Infectious Diseases Research Centre. He is also the Director of Centre of Excellence and a member of COVID-19 and Zika virus Task Forces in the Global Virus Network.
Availability
- Professor Alexander Khromykh is:
- Available for supervision
- Media expert
Fields of research
Qualifications
- Bachelor of Science, Tomsk State University
- Doctor of Philosophy, The Institute for Molecular Virology
Research interests
-
Molecular pathogenesis of RNA viruses
Viruses of main interest include West Nile virus, Zika virus and SARS-CoV-2 virus. A particular strength is in the developing infectious clones and replicons and utilising them to study virus replication, to identify viral determinants of pathogenicity and to develop vaccines and antivirals.
-
Evasion of host antiviral response by pathogenic RNA viruses
We apply advanced molecular methodologies including screening with viral RNAi libraries to identify new host antiviral genes and to dissect mechanisms employed by pathogenic RNA viruses to evade antiviral responses.
-
The role of viral and host noncoding RNAs in virus-host interaction
We study biogenesis of novel viral noncoding RNAs and elucidate mechanisms by which both, viral and host noncoding RNAs shape the outcomes of infection with pathogenic RNA viruses.
Research impacts
The main areas of research of the group are molecular virology, viral pathogenesis, and virus-host interactions. The viruses studied in the group are pathogenic RNA viruses, viruses such as West Nile virus, Zika virus, and SARS-CoV-2 virus. The goal of the research is to determine the mechanisms by which these viruses cause disease in the hosts and to identify viral and host factors determining the outcome of infection. The group uses a range of classical and more modern approaches including molecular manipulations with viral infectious cDNA clones and replicons, transient and stable expression of viral proteins and noncoding RNAs, viral replication and virulence assays, deep mutational scanning, mass spectrometry, next generation sequencing, siRNA knockdowns, and knockout cells and mice. Together, these approaches allow the group to perform detailed analysis of the effects of changes in the viral and host genomes that are likely to have a profound impact on virus replication and pathogenesis. The obtained knowldge is also applied to develop novel vaccine platforms and test antivirals.
Works
Search Professor Alexander Khromykh’s works on UQ eSpace
2010
Journal Article
RNA structures required for production of subgenomic flavivirus RNA
Funk, Anneke, Truong, Katherine, Nagasaki, Tomoko, Torres, Shessy, Floden, Nadia, Balmori Melian, Ezequiel, Edmonds, Judy, Dong, Hongping, Shi, Pei-Yong and Khromykh, Alexander A. (2010). RNA structures required for production of subgenomic flavivirus RNA. Journal of Virology, 84 (21), 11407-11417. doi: 10.1128/JVI.01159-10
2010
Journal Article
Chikungunya virus nonstructural protein 2 inhibits type I/II interferon-stimulated JAK-STAT signaling
Fros, Jelke J., Liu, Wen Jun, Prow, Natalie A., Geertsema, Corinne, Ligtenberg, Maarten, Vanlandingham, Dana L., Schnettler, Esther, Vlak, Just M., Suhrbier, Andreas, Khromykh, Alexander A. and Pijlman, Gorben P. (2010). Chikungunya virus nonstructural protein 2 inhibits type I/II interferon-stimulated JAK-STAT signaling. Journal of Virology, 84 (20), 10877-10887. doi: 10.1128/JVI.00949-10
2010
Journal Article
Nanopatch-targeted skin vaccination against West Nile virus and chikungunya virus in mice
Prow, Tarl W., Chen, Xianfeng, Prow, Natalie A., Fernando, Germain J. P., Tan, Cindy S. E., Raphael, Anthony P., Chang, David, Ruutu, Merja P., Jenkins, Derek W. K., Pyke, Alyssa, Crichton, Michael L., Raphaelli, Kristin, Goh, Lucas Y. H., Frazer, Ian H., Roberts, Michael S., Gardner, Joy, Khromykh, Alexander A., Suhrbier, Andreas, Hall, Roy A. and Kendall, Mark A. F. (2010). Nanopatch-targeted skin vaccination against West Nile virus and chikungunya virus in mice. Small, 6 (16), 1776-1784. doi: 10.1002/smll.201000331
2010
Journal Article
The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signaling
Laurent-Rolle, Maudry, Boer, Elena F., Lubick, Kirk J., Wolfinbarger, James B., Carmody, Aaron B., Rockx, Barry, Liu, Wenjun, Ashour, Joseph, Shupert, W. Lesley, Holbrook, Michael R., Barrett, Alan D., Mason, Peter W., Bloom, Marshall E., Garcia-Sastre, Adolfo, Khromykh, Alexander A. and Best, Sonja M. (2010). The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signaling. Journal of Virology, 84 (7), 3503-3515. doi: 10.1128/JVI.01161-09
2010
Journal Article
Viral determinants in the NS3 helicase and 2K peptide that promote West Nile virus resistance to antiviral action of 2′,5′-oligoadenylate synthetase 1b
Mertens, E, Kajaste-Rudnitski, A, Torres, S, Funk, A, Frenkiel, MP, Iteman, I, Khromykh, AA and Despres, P (2010). Viral determinants in the NS3 helicase and 2K peptide that promote West Nile virus resistance to antiviral action of 2′,5′-oligoadenylate synthetase 1b. Virology, 399 (1), 176-185. doi: 10.1016/j.virol.2009.12.036
2010
Journal Article
NS1 ' of flaviviruses in the Japanese encephalitis virus serogroup is a product of ribosomal frameshifting and plays a role in viral neuroinvasiveness
Balmori Melian, Ezequiel, Hinzman, Edward, Nagasaki, Tomoko, Firth, Andrew E., Wills, Norma M., Nouwens, Amanda S., Blitvich, Bradley J., Leung, Jason, Funk, Anneke, Atkins, John F., Hall, Roy and Khromykh, Alexander A. (2010). NS1 ' of flaviviruses in the Japanese encephalitis virus serogroup is a product of ribosomal frameshifting and plays a role in viral neuroinvasiveness. Journal of Virology, 84 (3), 1641-1647. doi: 10.1128/JVI.01979-09
2010
Conference Publication
Sneaking up on West Nile Virus NS2B/NS3 protease subcellular activity utilising dye-quenched substrates
Liebscher, Susan, Chappell, K. J., Stoermer, Martin J., Watterson, Daniel, Webb, Richard I., Khromykh, Alexander A., Fairlie, David P. and Young, Paul R. (2010). Sneaking up on West Nile Virus NS2B/NS3 protease subcellular activity utilising dye-quenched substrates. PlusStrand 2010: The Ninth International Symposium on Positive-Strand RNA Viruses, Atlanta, GA, U.S.A., 17-21 May 2010.
2009
Journal Article
Monoclonal antibodies to the West Nile virus NS5 protein map to linear and conformational epitopes in the methyltransferase and polymerase domains
Hall, Roy A., Tan, Si En, Selisko, Barbara, Slade, Rachael, Hobson-Peters, Jody, Canard, Bruno, Hughes, Megan, Leung, Jason Y., Balmori-Melian, Ezequiel, Hall-Mendelin, Sonja, Pham, Kim B., Clark, David C., Prow, Natalie A. and Khromykh, Alexander A. (2009). Monoclonal antibodies to the West Nile virus NS5 protein map to linear and conformational epitopes in the methyltransferase and polymerase domains. Journal of General Virology, 90 (12), 2912-2922. doi: 10.1099/vir.0.013805-0
2009
Journal Article
Generating flavivirus vaccine candidates by modulating interferon sensitivity
Funk, Anneke and Khromykh, Alexander (2009). Generating flavivirus vaccine candidates by modulating interferon sensitivity. Expert Review of Vaccines, 8 (9), 1157-1160. doi: 10.1586/ERV.09.73
2009
Journal Article
West Nile virus: The current climate
Prow, Natalie A., Khromykh, Alexander A. and Hall, Roy A. (2009). West Nile virus: The current climate. Medical Laboratory Observer, 41 (4), 10-15.
2009
Journal Article
A Kunjin replicon vector encoding granulocyte macrophage colony-stimulating factor for intra-tumoral gene therapy
Hoang-Le, D., Smeenk, L., Anraku, I., Pijlman, G. P., Wang, X. J., De Vrij, J., Liu, W. J., Le, T. T., Schroder, W. A., Khromykh, Alexander A. and Suhrbier, A. (2009). A Kunjin replicon vector encoding granulocyte macrophage colony-stimulating factor for intra-tumoral gene therapy. Gene Therapy, 16 (2), 190-199. doi: 10.1038/gt.2008.169
2009
Conference Publication
Evasion of host innate immune response by West Nile virus.
Khromykh, A. (2009). Evasion of host innate immune response by West Nile virus.. TLROZ 2009: Patterns Recognition Receptors in Health and Disease, Surfers Paradise, Australia, 28-30 October 2009.
2009
Book Chapter
Vaccine development against West Nile Virus
Khromykh, Alexander A., Chang, David C. and Hall, Roy A. (2009). Vaccine development against West Nile Virus. West Nile Encephalitis Virus Infection: Viral Pathogenesis and the Host Immune Response. (pp. 427-451) edited by Diamond, Michael S.. New York: Springer Science + Business Media. doi: 10.1007/978-0-387-79840-0_20
2009
Conference Publication
Molecular basis for the resistance of West Nile virus to antiviral activity of Oas1b
Martens, E., Iteman, I., Frenkiel, M.-P., Simon-Chazottes, D., Funk, A., Khromykh, A. and Kajaste-Rudnitski, P. (2009). Molecular basis for the resistance of West Nile virus to antiviral activity of Oas1b. 28th Annual Meeting of American Society for Virology, Vancouver, Canada, 11-15 July 2009.
2009
Conference Publication
The role of pseudoknot interactions in stabilizing flavivirus RNA structure and generation of nuclease resistant flavivirus RNA.
Truong, K., Funk, A., Torres, S. and Khromykh, A. (2009). The role of pseudoknot interactions in stabilizing flavivirus RNA structure and generation of nuclease resistant flavivirus RNA.. 5th Australian Virology Group Meeting, Lorne, Australia, 13-17 December 2009.
2009
Conference Publication
The role of flavivirus subgenomic non-coding RNA in overcoming host innate immune response
Funk, A., Torres, S., Truong, K., Edmonds, J., Pijlman, G., Hall, R., Lobigs, M., Kumagai, Y., Takeuchi, O., Akira, S. and Khromykh, A. (2009). The role of flavivirus subgenomic non-coding RNA in overcoming host innate immune response. TLROZ 2009: Patterns Recognition Receptors in Health and Disease, Gold Coast , Australia, 28-30 October 2009.
2009
Conference Publication
The role of subgenomic non-coding RNA in flavivirus-host interactions and viral pathogenicity
Khromykh, A., Funk, A., Torres, S., Edmonds, J., Pijlman, G., Hall, R., Lobigs, M., Kumagai, Y., Takeuchi, O. and Akira, S. (2009). The role of subgenomic non-coding RNA in flavivirus-host interactions and viral pathogenicity. 28th Annual Meeting of American Society for Virology, Vancouver, Canada, 11-15 July 2009.
2009
Conference Publication
Flavivirus subgenomic non-coding RNA is required to overcome the host innate immune response
Funk, A., Torres, S., Edmonds, J., Pijlman, G., Hall, R., Lobigs, M., Kumagai, Y., Takeuchi, O., Akira, S. and Khromykh, A. (2009). Flavivirus subgenomic non-coding RNA is required to overcome the host innate immune response. 5th Australian Virology Group Meeting, Lorne, Australia, 13-17 December 2009. Australia: Australian Virology Group.
2009
Conference Publication
The role of small subgenomic RNA in flavivirus replication and pathogenicity.
Khromykh, A. (2009). The role of small subgenomic RNA in flavivirus replication and pathogenicity.. NITD Conference on Dengue, Manila, Philippines, 31 Aug - 4 Sept 2009.
2008
Journal Article
A highly structured,nuclease-resistant, noncoding RNA produced by flaviviruses is required for pathogenicity
Pijlman, Gorben P., Funk, Anneke, Kondratieva, Natasha, Leung, Jason, Torres, Shessy, Van der Aa, Lieke, Liu, Wen Jun, Palmenberg, Ann C., Shi, Pei-Yong, Hall, Roy A. and Khromykh, Alexander A. (2008). A highly structured,nuclease-resistant, noncoding RNA produced by flaviviruses is required for pathogenicity. Cell Host and Microbe, 4 (6), 579-591. doi: 10.1016/j.chom.2008.10.007
Funding
Current funding
Past funding
Supervision
Availability
- Professor Alexander Khromykh is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Available projects
-
Cooperation between sfRNA and non-structural protein NS5 for flavivirus immune evasion
This Earmarked Scholarship project is aligned with a recently awarded Category 1 research grant. It offers you the opportunity to work with leading researchers and contribute to large projects of national significance.
Flaviviruses are important human pathogens that include West Nile, Dengue, Zika, Yellow fever virus and other viruses. They have a unique ability to produce viral noncoding RNA from their 3' untranslated region by hijacking host exoribonuclease. This RNA, termed subgenomic flaviviral RNA (sfRNA), accumulates in infected cells in high abundance and facilitates viral pathogenesis by supressing antiviral response. However, the molecular mechanism that determines this activity is not fully elucidated. Recently we have discovered that sfRNA of Zika virus executes this function in cooperation with the viral protein NS5. We found that sfRNA binds to and stabilises NS5, allowing this protein to inhibit phosphorylation of transcriptional factor STAT1, a key mediator of antiviral signalling.
This project is aimed to uncover how sfRNA binding effects NS5 conformation and its ability to inhibit STAT1 phosphorylation by identifying interacting sites in both molecules, characterising structural changes in NS5 caused by sfRNA binding and creating mutant viruses incapable of sfRNA-NS5 interactions. It will also investigate whether this mechanism is conserved between all flaviviruses.
The successful candidate will have an opportunity to join one of the leading flavivirus laboratories and work in the dynamic team of internationally recognised experts at the forefront of flavivirus research. He/she will obtain experience in the wide range of classical and modern research techniques such as cryo-electron microscopy, next generation sequencing, generation of mutant viruses, immunofluorescent virus detection, quantitative PCR, Northern blotting, electrophoretic mobility shift assay, etc. He/she will have an opportunity to communicate their research at the national and international conferences and publish in the leading academic journals.
-
Predicting and preparing for the unfolding evolution of SARS-CoV-2
This Earmarked Scholarship project is aligned with a recently awarded Category 1 research grant. It offers you the opportunity to work with leading researchers and contribute to large projects of national significance.
SARS-CoV-2 is the cause of current COVID-19 pandemic which has already infected >270 million people and killed >5 million of them. Currently deployed and future vaccines are likely to significantly decrease the burden of pandemic, however, new viral variants are emerging that are less susceptible to vaccine-induced immunity. Hence, deeper understanding of what drives viral evolution under the pressure of vaccine-induced immune responses is needed to predict and prepare for the emergence of future variants and inform development of more effective vaccines. The project will employ deep mutational scanning methodology to identify changes in the viral spike protein responsible for altered susceptibility to vaccine-induced antibodies. The implications of identified changes on the properties of spike protein and susceptibility to vaccine-induced antibodies will be investigated using structural analysis and various functional assays. The findings will be critical for predicting viral changes that are likely to emerge in the landscape of vaccinations and provide invaluable information for pre-emptive development of vaccines that will be able to minimise future emergence of vaccine-resistant variants.
Supervision history
Current supervision
-
Doctor Philosophy
Predicting and preparing for the unfolding evolution of SARS-CoV-2
Principal Advisor
Other advisors: Dr Rhys Parry
-
Doctor Philosophy
Predicting and preparing for the unfolding evolution of SARS-CoV-2
Principal Advisor
Other advisors: Dr Rhys Parry
-
Doctor Philosophy
Cooperation between sfRNA and non-structural protein NS5 for flavivirus immune evasion
Principal Advisor
Other advisors: Dr Naphak Modhiran, Dr Andrii Slonchak
-
Doctor Philosophy
Engineering chimeric viruses as protective and safe vaccines against mosquito-borne viral disease
Associate Advisor
Other advisors: Dr Andrii Slonchak, Associate Professor Jody Peters
-
Doctor Philosophy
Mechanisms of host restriction underpinning the safety and efficacy of novel chimeric flaviviral vaccines
Associate Advisor
Other advisors: Associate Professor Jody Peters, Dr Natalee Newton
-
Doctor Philosophy
Functions of Noncoding Viral RNA in Insect-Specific Flaviviruses
Associate Advisor
Other advisors: Dr Andrii Slonchak
-
Doctor Philosophy
Why certain viruses don't get along in mosquitoes: Dissecting the mechanism of superinfection exclusion
Associate Advisor
Other advisors: Dr Andrii Slonchak
Completed supervision
-
2023
Doctor Philosophy
Uncovering host determinants of Zika virus replication using an in vivo and in vitro RNAi screening approach
Principal Advisor
-
2022
Doctor Philosophy
Uncovering molecular determinants in ZIKV-NS5 related to replication, virulence, and transmissibility
Principal Advisor
-
2015
Doctor Philosophy
Characterisation of the Flaviviral Non-Structural Protein NS1'
Principal Advisor
-
2014
Doctor Philosophy
Second Generation Single-Round Infectious Particle (SRIP)-Producing Flavivirus Vaccine
Principal Advisor
-
-
2010
Doctor Philosophy
Role of nonstructural protein NS2A in Flavivirus assembly and secretion
Principal Advisor
-
2005
Master Philosophy
INFECTION OF HUMAN MONOCYTE-DERIVED DENDRITIC CELLS WITH KUNJIN VIRUS IN VITRO
Principal Advisor
-
2013
Doctor Philosophy
Defining regions of interaction between the MTase and POL domains of West Nile virus NS5 as potential targets for antiviral drug design
Joint Principal Advisor
-
2018
Doctor Philosophy
Molecular Mechanisms of Evolutionary Adaption in Insect-specific Flaviviruses
Associate Advisor
Other advisors: Associate Professor Jody Peters
-
2015
Doctor Philosophy
The role of the type I interferon in the immunobiology of chikungunya virus.
Associate Advisor
-
2014
Doctor Philosophy
Understanding immunobiology of chikungunya virus disease using mouse models
Associate Advisor
-
2013
Doctor Philosophy
Stalking the West Nile Virus NS2B/NS3 protease as a target for infection control and as a key player in virus factories
Associate Advisor
Other advisors: Professor David Fairlie
-
2011
Doctor Philosophy
Characterisation Of Intracellular Replication and Pathogenesis of Murine Norovirus 1
Associate Advisor
-
2009
Doctor Philosophy
The interferon-induced antiviral protein MxA: functional and therapeutic aspects relating to virus infection
Associate Advisor
-
-
2005
Doctor Philosophy
INDUCTION OF LONG LASTING PROTECTIVE CD8+ T LYMPHOCYTE RESPONSES BY KUNJIN REPLICON-BASED VACCINE VECTORS
Associate Advisor
Media
Enquiries
Contact Professor Alexander Khromykh directly for media enquiries about:
- COVID-19
- Ebola virus
- Flaviviruses
- Gene delivery systems
- Gene expression
- Immunisation
- Molecular virology
- Noncoding RNAs
- SARS-CoV-2
- Vaccines
- Virus-host interactions
- Viruses
- West Nile Virus
- Zika virus
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: